Binedaline

This classification denotes an antidepressant agent with the molecular formula C19H23N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3AVG9P140R, chemically known as 1,2-ethanediamine, n,n,n-trimethyl-n-(3-phenyl-1h-indol-1-yl)- but generally known as binedaline, which bears US NIH Compound Identifier 42510. Binedaline most often comes in base and hydrochloride forms. European Medicines Agency schedules Binedaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05835MIG. The term BINEDALINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). BINEDALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule binedaline under HS 29339990 and SITC 51577. As of Q4 2014, BINEDALINE remains the US FDA Preferred Term for this commodity. Binedaline bears US NLM identifiers UMLS ID C0053611 and NCI Concept Code C72722. SMILES: n1(N(CCN(C)C)C)c2c(c(c1)c1ccccc1)cccc2.